Physician

Matthew David Mclaughlin, D.O.

According to 2025 Medicare claims, Matthew Mclaughlin, D.O. (NPI: 1215071469) practices urology in the Coeur d'Alene, ID market, with the plurality of this provider's patient population coming from Kootenai, ID. This provider's primary affiliated billing organization is NORTH IDAHO UROLOGY, PLLC (NPI: 1891834768; TIN: 82-0533076) and primary practice location at 83814-2668. Mclaughlin is affiliated with the MaineHealth Accountable Care Organization (ACO ID: A1290), Kootenai Accountable Care, LLC (ACO ID: A3621), Caravan Collaborative Pathways (ACO ID: A4604), and Caravan Health ACO 50 LLC (ACO ID: A5160), participating under the MSSP model.

Mclaughlin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 675 traditional Medicare patients, billed 13,867 HCPCS/CPT codes, and received $387,959 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,881 prescription claims across 564 beneficiaries totaling $4,079,442 in drug costs, led by Xtandi (Enzalutamide). DME data shows 261 claims. Open Payments data shows 42 records totaling $1,121. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $265,946 and ending at $387,959. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $126,314 to $4,079,442. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	697	5,168	$265,946
2016	701	5,291	$252,619
2017	758	7,278	$375,126
2018	784	8,940	$478,569
2019	857	12,514	$369,387
2020	753	13,283	$343,945
2021	731	10,680	$474,590
2022	693	11,412	$349,076
2023	674	12,973	$460,522
2024	675	13,867	$387,959

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	417	2,054	$126,314
2016	453	2,280	$123,384
2017	440	2,178	$202,065
2018	472	2,236	$578,227
2019	479	2,068	$917,082
2020	425	1,862	$1,127,197
2021	440	1,756	$1,639,456
2022	482	2,107	$2,128,097
2023	477	2,301	$3,418,907
2024	564	2,881	$4,079,442

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	37	310	$39,801
2016	47	395	$60,098
2017	38	440	$76,745
2018	48	457	$92,082
2019	63	353	$90,293
2020	26	497	$83,903
2021	38	343	$80,317
2022	28	278	$61,751
2023	19	255	$59,112
2024	19	261	$37,540

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	312	384	$84
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	262	309	$60
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	331	411	$12
51798	Ultrasound measurement of bladder capacity after voiding	200	256	$8
81003	Automated urinalysis test	235	302	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	135	4,050	$1,872,499
Erleada	Apalutamide	63	1,890	$862,352
Orgovyx	Relugolix	265	7,950	$688,381
Abiraterone Acetate	Abiraterone Acetate	174	5,220	$292,448
Nubeqa	Darolutamide	15	450	$209,848

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	19	77	$22,723
A4385	Ostomy skin barrier, solid 4 x 4 or equivalent, extended wear, without built-in convexity, each	N	N/R	20	$4,075
A4430	Ostomy pouch, urinary, with extended wear barrier attached, with built-in convexity, with faucet-type tap with valve (1 piece), each	N	N/R	13	$3,691
A4407	Ostomy skin barrier, with flange (solid, flexible, or accordion), extended wear, with built-in convexity, 4 x 4 inches or smaller, each	N	N/R	12	$2,463
A4432	Ostomy pouch, urinary; for use on barrier with non-locking flange, with faucet-type tap with valve (2 piece), each	N	N/R	15	$1,265

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	42	$1,121	Dendreon Pharmaceuticals LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Matthew David Mclaughlin, D.O.?

Tedicare shows public-source Medicare data for Matthew David Mclaughlin, D.O. (NPI 1215071469), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew David Mclaughlin, D.O. have ACO affiliation data?

Matthew David Mclaughlin, D.O. is shown with ACO affiliation data for MaineHealth Accountable Care Organization (MSSP, ACO ID A1290), Kootenai Accountable Care, LLC (MSSP, ACO ID A3621), Caravan Collaborative Pathways (MSSP, ACO ID A4604), and Caravan Health ACO 50 LLC (MSSP, ACO ID A5160).

What billing organization is linked to Matthew David Mclaughlin, D.O.?

Matthew David Mclaughlin, D.O. is linked to NORTH IDAHO UROLOGY, PLLC (billing NPI 1891834768) in the available physician profile data.

Does Matthew David Mclaughlin, D.O. have Open Payments data?

Matthew David Mclaughlin, D.O. has 42 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.